Spruce Biosciences Inc. (SPRB)
NASDAQ: SPRB
· Real-Time Price · USD
8.75
-0.55 (-5.93%)
At close: Jun 09, 2025, 3:57 PM
8.75
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT
Spruce Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -55.45M | -53.04M | -39.43M | -43.11M | -46.75M | -47.92M | -49.11M | -48.16M | -47.21M | -46.18M | -44.22M | -44.27M | -44.17M | -42.29M | -41.45M | -39.59M | -34.26M |
Depreciation & Amortization | 37K | 46K | 53K | 60K | 66K | 70K | 78K | 84K | 72K | 74K | 70K | 65K | 76K | 68K | 58K | 48K | 48K |
Stock-Based Compensation | 4.33M | 5.35M | 5.61M | 5.59M | 5.12M | 4.62M | 4.2M | 3.86M | 3.55M | 3.63M | 3.63M | 3.87M | 3.98M | 3.96M | 3.57M | 2.76M | 1.84M |
Other Working Capital | -3M | -6.53M | -11.55M | -11.85M | 6.9M | 23.45M | 26.8M | 30.93M | 14.51M | 194K | -1.38M | -1.5M | -381K | 888K | -3.34M | -2.44M | -1.78M |
Other Non-Cash Items | 189K | 3.28M | 4.28M | 4.28M | 4.27M | 1.06M | -709K | -681K | -653K | -392K | 387K | 380K | 374K | 313K | 273K | 221K | 2.67M |
Deferred Income Tax | n/a | n/a | -1.07M | -1.21M | -1.46M | -1.46M | -387K | -249K | n/a | n/a | 61K | 118K | 121K | 121K | 60K | 3K | n/a |
Change in Working Capital | -3.6M | -8.57M | -12.91M | -12.12M | 5.34M | 10.36M | 12.12M | 15.03M | 2.54M | 1.13M | 280K | 1.01M | 701K | 1.96M | 2.14M | 1.21M | 1.87M |
Operating Cash Flow | -53.73M | -55.96M | -46.5M | -49.54M | -36.44M | -33.27M | -33.8M | -30.11M | -41.65M | -41.68M | -39.74M | -38.76M | -38.92M | -35.88M | -35.34M | -35.34M | -30.35M |
Capital Expenditures | n/a | n/a | n/a | -7K | -7K | -7K | -13K | -8K | -14K | -14K | -14K | -77K | -74K | -93K | -111K | -89K | -93K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4M | -4M | -4M | -64.83M | -60.83M | -60.83M | -60.83M | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -11.88M | -14.81M | -35.7M | -37.69M | -36.8M | -39.85M | -31.23M | -90.07M | -79.08M | -73.1M | -60.83M | n/a |
Sales Maturities Of Investments | n/a | n/a | 9.3M | 23.3M | 45.3M | 67.67M | 75.86M | 65.86M | 79.36M | 60.5M | 43.12M | 39.12M | 3.62M | 121K | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 9.3M | 23.3M | 45.3M | 55.78M | 46.49M | 36.49M | 48M | 41.02M | 101.72M | 85.45M | -8.89M | -12.39M | -73.1M | -60.83M | n/a |
Investing Cash Flow | n/a | n/a | 9.3M | 23.29M | 45.29M | 55.78M | 61.05M | 30.16M | 41.67M | 23.69M | 3.14M | 7.7M | -86.64M | -79.17M | -73.21M | -60.92M | -93K |
Debt Repayment | -1.22M | -1.62M | -1.62M | -1.62M | -1.62M | -1.62M | -1.22M | -811K | -405K | n/a | n/a | n/a | n/a | 220K | 220K | 220K | 220K |
Common Stock Repurchased | -11K | -13K | -230K | -230K | -290K | -288K | 5K | -35K | 36K | 36K | 94K | 134K | 134K | 134K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -589K | n/a | 290K | 290K | 223K | -2.64M | -2.67M | -2.72M | -2.79M | -201K | -70K | -3K | 272K | 423K | 94.54M | 93.73M | 93.46M |
Financial Cash Flow | -1.81M | -1.62M | -1.55M | -1.55M | -1.62M | 49.14M | 49.73M | 50.04M | 50.38M | -241K | -110K | -3K | 272K | 643K | 94.76M | 137.94M | 137.66M |
Net Cash Flow | -55.54M | -57.59M | -38.75M | -27.8M | 7.23M | 71.64M | 76.97M | 50.09M | 50.4M | -18.23M | -36.71M | -31.07M | -125.28M | -114.4M | -13.79M | 41.68M | 107.22M |
Free Cash Flow | -53.73M | -55.96M | -46.5M | -49.55M | -36.45M | -33.28M | -33.82M | -30.12M | -41.66M | -41.7M | -39.76M | -38.84M | -38.99M | -35.97M | -35.45M | -35.43M | -30.44M |